Skip to main content
OpenTrials

Clinical trial condition

Actinomycetales Infections

Explore clinical trials studying Actinomycetales Infections. Study availability and eligibility vary by location and protocol.

1,556 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Actinomycetales Infections trial results

Completed

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
  • GSK Investigational Site Novara, Piedmont, Italy
  • GSK Investigational Site Cagliari, Sardinia, Italy
View Trial Details
Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

NCT01738477

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fullerton, California, United States
View all 20 locations
View Trial Details
Completed

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

NCT01979900

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Jin Chengjiang Center for Diseases Control and Prevention, Hechi, Guangxi Hechi, Guangxi, China
  • Liucheng County Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
  • Liuzhou Center for Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
  • Rongshui County Diseases Control and Prevention, Liuzhou, Guangxi Liuzhou, Guangxi, China
View Trial Details
Completed

Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa

NCT02391415

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Children's Infectious Diseases Clinical Research Unit, Tygerberg Hospital Cape Town, South Africa
  • Desmond Tutu TB Centre Cape Town, South Africa
  • South African Tuberculosis Vaccine Initiative Cape Town, South Africa
  • The Respiratory and Meningeal Pathogens Reserach Unit Johannesburg, South Africa
View Trial Details

Related conditions